Publikationen, an denen er mitarbeitet Ana Urzainqui (14)

2023

  1. Analysis of the interstitial lung disease pathogenesis in PSGL-1 KO and P-Selectin KOmice

    44 Congreso de las Sociedad Española de Inmunología

  2. Diagnostic predictive value of soluble PSGL-1 and its ligands in patients with Systemicsclerosis (SSc)

    44 Congreso de las Sociedad Española de Inmunología

  3. Interstitial Lung Disease Associated with Systemic Sclerosis; New Molecules, New Routes of Administration

    JOURNAL OF PHARMACEUTICAL ANALYSIS, Vol. 12

  4. Low P-Selectin Glycoprotein Ligand-1 Expression in Neutrophils Associates with Disease Activity and Deregulated NET Formation in Systemic Lupus Erythematosus

    International Journal of Molecular Sciences, Vol. 24, Núm. 7, pp. 6144

  5. P-selectin/PSGL-1 axis regulation of autophagy in monocytes from healthy donors andlupus patients

    44 Congreso de las Sociedad Española de Inmunología

  6. PSGL-1/P-selectin interaction reduces the amount of DNA released in monocytesextracelular traps: lack of regulation in SLE patients

    44 Congreso de las Sociedad Española de Inmunología

2022

  1. Characterization of interstitial lung disease present in PSelectin KO mice (Lupus-likesyndrome) and PSGL-1 KO mice (Scleroderma-like syndrome)

    43 Congreso de las Sociedad Española de Inmunología

2021

  1. Efecto del everolimus en el tratamiento de la neumonía intersticial asociada a esclerosissistémica en ratones PSGL-1 KO

    42 Congreso de la Sociedad Española de Inmunología

  2. Intratracheal Instillation of Everolimus Included In HA-decorated Liposomes, as SSc-ILDTreatment in mice

    Nanotechnology and Chronic Diseases

  3. PSGL-1/P-Selectin interaction controls generation of NETs in human neutrophils

    42 Congreso de la Sociedad Española de Inmunología

2020

  1. Estudio preliminar del tratamiento con Everolimus de la neumonía intersticial asociada aesclerosis sistémica en ratones PSGL-1 KO

    XLVI Congreso Nacional de la SER

2019

  1. Low ERA expression might be implicated in the development of pulmonary hypertensionin female mice lacking PSGL-1

    Annual European Congress of Rheumatology 2019

  2. Presence of PSGL-1 and ADAM8 in the Neutrophil Extracellular Traps

    41 Congreso de la Sociedad Española de Inmunología

2018

  1. Deregulated PSGL-1 Expression in B Cells and Dendritic Cells May Be Implicated in Human Systemic Sclerosis Development

    Journal of Investigative Dermatology, Vol. 138, Núm. 10, pp. 2123-2132